Synjardy 12.5/850 mg

Description

Product Description:

Synjardy 12.5/850 mg

Synjardy 12.5/850 mg contains two active substances empagliflozin and metformin. Each belongs to a group of medicines called “oral anti-diabetics”. These are medicines taken by mouth to treat type 2 diabetes.

• Empagliflozin belongs to a group of medicines called sodium glucose co-transporter-2 (SGLT2) inhibitors. It works by blocking the SGLT2 protein in your kidneys. This causes blood sugar (glucose) to be removed in your urine.
• Metformin works in a different way to lower blood sugar levels, mainly by blocking glucose production in the liver.
• Thereby this medicine lowers the amount of sugar in your blood. This medicine can also help prevent heart disease.

Prescription Required*